Clinical Trials Search Results - National Cancer Institute

Clinical Trials Search Results - National Cancer Institute

1.

Surgery Alone, Surgery With Cyclophosphamide, Vinblastine, and Prednisolone (CVP), or CVP Alone in Treating Young Patients With Stage IA or Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Status: Active
Phase: Phase IV
Type: Treatment
Age: 17 and under
Trial IDs: CDR0000667369, NCI-2014-02026, EU-21011, EUDRACT-2007-004092-19, EURONET-PHL-LP1, NCT01088750

2.

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 3066K1-4438, NCI-2014-00131, 2009-015498-11, B1771007, NCT01180049

3.

Transurethral Resection of Bladder Tumors Using PK Button Vaporization Electrode or Monopolar Loop Electrocautery in Treating Patients with Bladder Cancer

Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 to 89
Trial IDs: WCI2119-11, NCI-2013-00065, IRB00053735, NCT01567462

4.

Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System

Status: Active
Phase: Phase IV
Type: Treatment
Age: 40 and over
Trial IDs: CTPR-0009, NCI-2013-01601, NCT01644669

5.

An Extension (Rollover) Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol

Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: GO28399, NCI-2013-01160, 2012-003144-80, NCT01739764

6.

Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer

Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: CDM00047339, NCI-2016-00348, E7059, NCT01774019

7.

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

Status: Active
Phase: Phase IV
Type: Treatment
Age: Any age
Trial IDs: CRAD001C2X01B, NCI-2013-01151, NCT01789281

8.

Sorafenib Tosylate in Treating Patients with Advanced Liver Cancer and Hepatitis C Infection

Status: Active
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-213, NCI-2013-01103, NCT01849588

9.

Cancer Venous Thromboembolism (VTE)

Status: Active
Phase: Phase IV
Type: Natural history/Epidemiology
Age: 18 and over
Trial IDs: DU176b-D-U311, NCI-2015-01358, 2014-004708-30, NCT02073682

10.

Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer

Status: Active
Phase: Phase IV
Type: Natural history/Epidemiology
Age: 18 and over
Trial IDs: 16913, NCI-2014-02038, NCT02141438

11.

Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Status: Active
Phase: Phase IV
Type: Treatment
Age: 70 and over
Trial IDs: ABI-007-NSCL-005, NCI-2014-02488, NCT02151149

12.

Behavioral Counseling and Nicotine Replacement Therapy or Varenicline in Helping Smokers Quit

Status: Active
Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Age: 18 to 65
Trial IDs: 2014-0207, NCI-2014-01485, NCT02162849

13.

Light Sedation or Intubated General Anesthesia in Reducing Complications and Length of Hospital Stay in Patients With Brain Cancer Undergoing Craniotomy

Status: Active
Phase: Phase IV
Type: Supportive care, Treatment
Age: 19 and over
Trial IDs: OSU-12161, NCI-2014-01110, 2014C0007, NCT02193568

14.

Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: B1871039, NCI-2014-02251, 2013-003250-25, NCT02228382

15.

Varenicline and Nicotine Replacement Therapy for Initial Smoking Cessation and Treatment in Smokers

Status: Active
Phase: Phase IV
Type: Behavioral study, Prevention
Age: 18 to 65
Trial IDs: 2014-0213, NCI-2015-00610, NCT02271919

16.

Perampanel in Lowering the Incidence of Seizures in Patients with Primary Glioma

Status: Active
Phase: Phase IV
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00055609, NCI-2015-00365, NCT02363933

17.

Vismodegib in Treating Patients with Locally Advanced or Recurrent Orbital or Periocular Basal Cell Cancer

Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: UMCC 2014.022, NCI-2015-00927, HUM00082579, ML29160, NCT02436408

18.

Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain after Surgery in Patients with Bladder Cancer

Status: Not yet active
Phase: Phase IV
Type: Health services research, Supportive care
Age: 18 and over
Trial IDs: 4B-14-4, NCI-2015-00279, NCT02438852

19.

A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel Treatment in Patients Who Have Previously Received Enzalutamide

Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 9785-MA-1008, NCI-2015-01197, NCT02441517

20.

Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation

Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 3200K1-4001, NCI-2010-01965, B2541006, NCT00672139

21.

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias

Status: Active
Phase: Phase IV
Type: Treatment
Age: 2 and over
Trial IDs: LA38-0411, NCI-2014-01229, NCT02041299

22.

Regadenoson Stress Echocardiogram in Detecting Coronary Artery Disease in Patients with Cancer

Status: Active
Phase: Phase IV
Type: Diagnostic
Age: 18 to 80
Trial IDs: 2013-0881, NCI-2014-01162, NCT02130453

23.

Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers

Status: Active
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: STUDY00001602, NCI-2015-01331, AD-1310-08709, NCI-2015-00937, NCT02244918

24.

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Status: Not yet active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: ML28979, NCI-2013-02161, NCT01868893

25.

An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy

Status: Not yet active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: ML29725, NCI-2015-01995, NCT02589717